In addition, we evaluated the feasibility of ADAM12 gene expression as a prognostic factor for hepatocellular carcinoma and predicted the possible ways that ADAM12 affects the progression of liver cancer, thereby providing a reliable basis for the prevention and prognosis of hepatocellular carcinoma. This evidence concerns the gene ADAM12 and liver cancer.